REFERENCES
- Azuma, T., Nagai, Y., Saito, T., Funauchi, M., Matsubara, T., & Sakoda, S. (1999). The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct demen-tia. Journal of Neurological Science, 162(1), 69–73.
- Barclay, L.L., Zemcov, A., Blass, J.P., & Sansone, J. (1985). Survival in Alzheimer's disease and vascular dementias. Neurology, 35, 834–840.
- Black, R.S., Barclay, L.L., Nolan, K.A., Thaler, H.T., Hardiman, ST., & Blass, J.P. (1992). Pentoxifylline in cerebrovascular dementia. Journal of the American Geriat-ric Society, 40(3), 237–244.
- Chui, H.C., Victoroff, J.I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992). Criteria for the diagnosis of ischemic vascular dementia proposed by the State of Cali-fornia Alzheimer' s Disease Diagnostic and Treatment Centers. Neurology, 42, 473–480.
- Cummings, J.L., & Trimble, M.R. (1995). Concise guide to neuropsychiatry and behavioral neurology (pp. 142–144). Washington, DC: American Psychiatric Press.
- Gorelick, P.B., Brody, J., Cohen, D., Freels, S., Levy, P., Dollear, W., Forman, H., & Harris, Y. (1993). Risk factors for dementia associated with multiple cerebral infarcts: A case-control analysis in predominantly African American hospital-based patients. Archives of Neurology, 50(7), 714–720.
- Hachinski, V. C., Lassen, N.A., & Marshall, J. (1974). Multi-infarct dementia: A cause of mental deterioration in the elderly. Lancet, 2, 207–209.
- Hier, D.B., Warach, J.D., Gorelick, P.B., & Thomas, J. (1989). Predictors of survival in clinically diagnosed Alzheimer' s disease and multi-infarct dementia. Archives of Neurology, 46(11), 1213–1216.
- Kase, C.S. (1991). Epidemiology of multi-infarct dementia. Alzheimer's Disease Assoc Disord, 5, 71–76.
- Kase, CS., Wolf, P.A., Bachman, DL., et al (1989). Dementia and stroke: The Framingham study. In M.D.Ginsberg & W.D. Dietrich (Eds.), Cerebrovascular diseases: Sixteenth research (Princeton) conference. (pp. 193–197). New York: Raven Press.
- Kertesz, A., & Clydesdale, S. (1994). Neuropsychological deficits in vascular dementia vs. Alzheimer's disease. Frontal lobe deficits prominent in vascular dementia. Ar-chives of Neurology, 51(12), 1226–1231.
- Konno, S., Meyer, J.S., Terayama, Y., Margishvili, G.M., & Mortel, K.F. (1997). Classification, diagnosis and treat-ment of vascular dementia. Drugs and Aging, 11(5), 361–373.
- Kwan, L. T., Reed, B.R., Eberling, J.L., Schuff, N., Tanabe, J., Norman, D., Weiner, MM., & Jagust, W.J. (1999). Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function. Archives of Neurology, 56(7), 809–814.
- Loeb, C. (1985). Vascular dementia. In J.A.M. Fredericks (Ed.), Handbook of clinical neurology. (Vol. 2). (pp. 353–369). Amsterdam: Elsevier.
- Loeb, C., Gandolfo, C., & Bino, G. (1988). Intellectual impairment and cerebral lesions in multiple cerebral infarcts: A clinical-computed tomography study. Stroke, 19, 560–565.
- Loeb, C., & Meyer, J.S. (1996). Vascular dementia: Still a debatable entity? Journal of Neurological Science, 143(1-2), 31–40.
- Marcusson, J., Rother, M., Kittner, B., Rossner, M., Smith, R.J., Babic, T., Folnegovic-Smalc, V., Moller, H.J., & Labs, K.H. (1997). A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM DI-R. The European Propentofylline Study Group. Dement Geriatr Cogn Disord, 8(5), 320–328.
- Meyer, J.S., Judd, B.W., Tawaklna, T., Rogers, R.L., & Mortel, K.F. (1986). Improved cognition after control of risk factors for multi-infarct dementia. Journal of the American Medical Association, 256, 2203–2209.
- Meyer, J.S., McClintic, K.L., Rogers R.L., Sims, P., & Mortel, K.F. (1988). Aetiological considerations and risk factors for multi-infarct dementia. JNeurolNeurosurg Psychiatry, 51, 1489–1497.
- Meyer, J.S., Obara, K., Muramatsu, K., Mortel, K.F., & Shirai, T. (1995). Cognitive performance after small strokes correlates with ischemia, not atrophy of the brain. Dementia, 6(6), 312–322.
- Molsa, P.K., Marttila, R.J., & Rinne, U.K. (1995). Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand, 91(3), 159–164.
- Roman, G.C., Tatemichi, T.K., Erkinjunti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., Amaducci, L., Orgogozo, J.M., Brun, A., Hofman, A., et al. (1993). Vascular demen-tia: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology, 43, 250–260.
- Sabri, O., Ringelstein, E.B., Hellwig, D., Schneider, R., Schreckenberger, M., Kaiser, H.J., Mull, M., & Buell, U. (1999). Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on Mill in patients with cerebral microangiopathy. Stroke, 30(3), 556–566.